Hedera Dx: Funding, Investors & Team (Sep 2026)
Liquid biopsies offer improved treatment options for a larger number of patients. Hedera Dx is committed to expanding access to advanced cancer treatment for the next billion people. We focus on developing NGS-based liquid biopsies that can be easily implemented in clinics, allowing for non-invasive diagnosis, timely treatment decisions, and ongoing disease tracking. Our company values include innovative thinking, modern approaches, and a human-centric culture, creating a dynamic and creative work atmosphere. Visit hederadx.com to find out more about joining our team.
Hedera Dx has raised $31.1M across 2 funding rounds on record, the most recent a Series A of $17.1M announced in May 2025.
That round is above the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
Hedera Dx Company Profile and Key Stats
Latest funding round on record: May 2025.
Hedera Dx Funding Rounds
Hedera Dx raised $14.0M in a Seed announced in Sep 2022.
2.7 years later, a Series A of $17.1M was announced in May 2025.
Hedera Dx Founders and Leadership Team
Contact details for the Hedera Dx team: 1 of 2 have an email address on file.
Start 14-day free trial →Hedera Dx Funding Compared to Other Health Care Startups
Hedera Dx's latest round of $17.1M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Hedera Dx in Health Care and Epalinges
Companies Similar to Hedera Dx
MoleSense is to provide a wearable skin sensor to help monitor high-risk pregnancies.
CeQur Simplicity helps people with diabetes by developing drug-delivery devices. They develop bolus insulin…
Calmea develops advanced contactless sensing systems that invisibly track sleep and automatically modify…
NUCLIDIUM is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for…
UNBOOUND is a medtech company and university spin-off (The Rockefeller University and University of Geneva)…
Christina Vallgren and Marcus Palm, two physicists from CERN, co-founded Terapet along with Professor Raymond…
Axmed is a company that specializes in serving low and middle-income countries (LMICs), with the goal of…
Babylat is an enricher device is the first automated, small-scale tabletop device for the protein enrichment…
Altiscreen is creating and producing cutting-edge, portable drug-of-abuse detection systems. With the use of…
Vivent provides growers, breeders and agrochem companies with actionable information direct from plants…
Multiwave develops breakthrough Magnetic Resonance Imaging and Positron Emission Tomography devices. Founded…
Hedera Dx Funding FAQs
What does Hedera Dx do?
Liquid biopsies offer improved treatment options for a larger number of patients. Hedera Dx is committed to expanding access to advanced cancer treatment for the next billion people. We focus on developing NGS-based liquid biopsies that can be easily implemented in clinics, allowing for non-invasive diagnosis, timely treatment decisions, and ongoing disease tracking. Our company values include innovative thinking, modern approaches, and a human-centric culture, creating a dynamic and creative work atmosphere. Visit hederadx.com to find out more about joining our team.
How much funding has Hedera Dx raised?
Hedera Dx has raised $31.1M across 2 rounds on record. The most recent is a Series A of $17.1M announced in May 2025.
When did Hedera Dx last raise funding?
Hedera Dx's most recent funding round on record is a Series A of $17.1M, announced in May 2025.
Who founded Hedera Dx?
FundedIQ lists Damien Lapray (Founder) at Hedera Dx.
Who is the CEO of Hedera Dx?
Tommi Lehtonen is listed as CEO at Hedera Dx.
Where is Hedera Dx headquartered?
Hedera Dx is based in Epalinges, Vaud, Switzerland.
How many employees does Hedera Dx have?
Hedera Dx is in the 11-50 employee band.
How does Hedera Dx's funding compare to other Health Care startups?
Hedera Dx's latest round of $17.1M is above the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's Hedera Dx Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Hedera Dx is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.